Merck & Co., Inc, RY818-B112, P.O. Box 2000, Rahway, New Jersey 07065, USA.
J Pharm Sci. 2009 Nov;98(11):4111-8. doi: 10.1002/jps.21703.
Three anhydrous polymorphs, a monohydrate and a dihydrate of an active pharmaceutical ingredient, N-{[(5S)-3-(4-{6-[(1R,5S)-6-cyano-3-oxabicyclo[3.1.0]hex-6-yl]pyridin-3-yl}phenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl}acetamide (Compound 1), have been crystallized and characterized. Slurry experiments and thermal data have been used to determine their relative thermodynamic stability. The hydrates of Compound 1 were found to be less stable than the most stable anhydrous Form I and converted into Form I in water within 15 min. The rate of conversion in a dry state was found to depend on the relative humidity (RH) and was highest at the two RH extremes examined, 5% and 97.5% RH.
三种无水多晶型物、一水合物和二水合物的活性药物成分 N-{[(5S)-3-(4-{6-[(1R,5S)-6-氰基-3-氧杂双环[3.1.0]己-6-基]吡啶-3-基}苯基)-2-氧代-1,3-恶唑烷-5-基]甲基}乙酰胺(化合物 1)已被结晶和表征。浆态实验和热数据已被用于确定它们的相对热力学稳定性。发现化合物 1 的水合物不如最稳定的无水形式 I 稳定,并且在 15 分钟内在水中转化为形式 I。在干燥状态下的转化速率被发现取决于相对湿度(RH),在两个所检查的 RH 极端值 5%和 97.5%RH 时最高。